These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 478268

  • 1. [A new therapeutic approach for terminating intact and disturbed pregnancies: three years of experience with the prostaglandin E2-derivative sulprostone (SHB 286) (author's transl)].
    Schmidt-Gollwitzer K, Schüssler B, Elger W, Schmidt-Gollwitzer M.
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):667-75. PubMed ID: 478268
    [Abstract] [Full Text] [Related]

  • 2. [Induction of abortion during the second and third trimester of pregnancy with sulprostone (author's transl)].
    Heinzl S, Winkler C.
    Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):231-6. PubMed ID: 7215768
    [Abstract] [Full Text] [Related]

  • 3. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z, Chwalisz K, Michałkiewicz W.
    Acta Chir Hung; 1986 Mar; 27(3):151-6. PubMed ID: 3825407
    [Abstract] [Full Text] [Related]

  • 4. [Sulprostone, a new prostaglandin E2 derivative (author's transl)].
    Schüssler B, Schmidt-Gollwitzer K, Schmidt-Gollwitzer M.
    Dtsch Med Wochenschr; 1979 Nov 30; 104(48):1697-701. PubMed ID: 520164
    [Abstract] [Full Text] [Related]

  • 5. [Comparative studies on the termination of intact and disturbed pregnancies by intramuscular application of 15(s)-15-methyl-prostaglandin F2alpha (author's transl)].
    Schridde H, Hickl EJ.
    Geburtshilfe Frauenheilkd; 1978 Oct 30; 38(10):845-8. PubMed ID: 700344
    [Abstract] [Full Text] [Related]

  • 6. [Combined pericervical and intramuscular administration of prostaglandin for the termination of pregnancy in the 2d and 3d trimester].
    Grünberger W, Husslein P.
    Geburtshilfe Frauenheilkd; 1983 Apr 30; 43(4):240-4. PubMed ID: 6553545
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Induction of abortion with sulprostone, a uteroselective prostaglandin E2 derivative: intramuscular route of application.
    Schmidt-Gollwitzer K, Hoebich D, Hardt W, Schuessler B, Schmidt-Gollwitzer M.
    Int J Fertil; 1981 Apr 30; 26(2):86-93. PubMed ID: 6114070
    [Abstract] [Full Text] [Related]

  • 10. [Priming of the cervix with prostaglandins in the first and second trimester].
    Brabec W.
    Wien Klin Wochenschr; 1982 Oct 29; 94(20):554-8. PubMed ID: 7168176
    [Abstract] [Full Text] [Related]

  • 11. [Termination of pregnancy and evacuation of the uterine contents in the second trimester. Use of a prostaglandin E2 analog: sulprostone].
    Barrat J, Cabrol D, Chouraqui A, Crépin G, Dumez Y, Hacker R, Henrion R, Magnin G, Soutoul JH, Sureau C.
    J Gynecol Obstet Biol Reprod (Paris); 1987 Oct 29; 16(1):93-9. PubMed ID: 3584870
    [Abstract] [Full Text] [Related]

  • 12. [Induced abortion after the 12th week of pregnancy. II].
    Blacquière JF, Treffers PE.
    Ned Tijdschr Geneeskd; 1979 Jun 30; 123(26):1110-4. PubMed ID: 460461
    [Abstract] [Full Text] [Related]

  • 13. [16-Phenoxy-prostaglandin-E2 for inducing abortion in intact and complicated pregnancy].
    Lichtenegger W.
    Geburtshilfe Frauenheilkd; 1984 Nov 30; 44(11):752-7. PubMed ID: 6569011
    [Abstract] [Full Text] [Related]

  • 14. [First results with a new prostaglandin E2-derivate (author's transl)].
    Schmidt-Gollwitzer M, Schmidt-Gollwitzer K, Schüssler B, Koch R, Nevinny-Stickel J.
    Geburtshilfe Frauenheilkd; 1977 Dec 30; 37(12):1030-8. PubMed ID: 604150
    [Abstract] [Full Text] [Related]

  • 15. [Therapeutic induction of abortion in the 1st and 2nd trimesters with intramuscular 15-methyl-prostaglandin F2 alpha].
    Göretzlehner G, Rudolf K, Frahm R.
    Zentralbl Gynakol; 1977 Dec 30; 99(22):1356-60. PubMed ID: 602503
    [Abstract] [Full Text] [Related]

  • 16. [Abortion induction in the 2d pregnancy trimester. Endocervical PGE2 gel administration, intramuscular sulprostone administration and combined (endocervical PGE2 gel/intramuscular sulprostone) treatment].
    Schmidt W, Rabe D, Hendrik HJ.
    Geburtshilfe Frauenheilkd; 1985 Apr 30; 45(4):261-4. PubMed ID: 3859450
    [Abstract] [Full Text] [Related]

  • 17. [Use of a new synthetic prostaglandin (sulprostone) in various obstetrical conditions].
    Melis GB, Fruzzetti F, Paoletti AM, Strigini F, Baisi F, Gargiulo T, Pallotti A, Solla E, Sesselego G, Fioretti P.
    Minerva Ginecol; 1982 Mar 30; 34(3):183-90. PubMed ID: 7045735
    [Abstract] [Full Text] [Related]

  • 18. Use of sulprostone for induction of preoperative cervical dilation or uterine evacuation: a comparison among the effects of different treatment schedules.
    Fruzzetti F, Melis GB, Strigini F, Vettori C, Ricci C, Fioretti P.
    Obstet Gynecol; 1988 Nov 30; 72(5):704-8. PubMed ID: 3173921
    [Abstract] [Full Text] [Related]

  • 19. [Outpatient termination of pregnancy via intramural single-shot application of the prostaglandin derivative sh b 286 (sulproston) (author's transl)].
    Wiechell H.
    Geburtshilfe Frauenheilkd; 1979 May 30; 39(5):401-3. PubMed ID: 456862
    [Abstract] [Full Text] [Related]

  • 20. The use of sulprostone, a prostaglandin E2 derivative, in intrauterine fetal death and therapeutic abortion.
    Lippert TH, Briel RC.
    Prostaglandins Med; 1980 Oct 30; 5(4):259-65. PubMed ID: 7443872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.